We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MOUNJARO Eli Lilly Australia Pty Ltd
Product name
MOUNJARO
Sponsor
Accepted date
Sep-2025
Active ingredients
tirzepatide
Proposed indication
Mounjaro (tirzepatide) is proposed to treat type 2 diabetes in people aged 10 and older when diet and exercise alone aren't sufficient. It can be used by itself if metformin can't be taken and may be taken with other medicines for diabetes.
Application type
C (new indication)
Publication date
Sep-2025